Renoprotective effects of SGLT2 inhibitors in patients with Fabry disease
SGLT2 inhibitors substantially attenuated the decline in eGFR in patients with FD. These findings support their potential as a renoprotective adjunct in the management of FD.
Authors
- Hideki Fujii (ORCID: https://orcid.org/0000-0001-7610-1068)
- Shunsuke Goto (ORCID: https://orcid.org/0000-0002-7102-2843)
- Hayaki Okamoto
- Mika Fujita
Institutions
- Kobe University (JP)
Publication Details
- Journal
- Molecular Genetics and Metabolism Reports
- Published
- 2025-10-18
- DOI
- https://doi.org/10.1016/j.ymgmr.2025.101271
- Citations
- 1
- Primary Topic
- Lysosomal Storage Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 1.16